trans-4-Methylcyclohexylisocyanate

Catalog No. :
ACMWNI291
CAS No. :
32175-00-1
Molecular Formula :
C8H13NO
Molecular Weight :
139.20

IUPAC Name:(1r,4r)-1-isocyanato-4-methylcyclohexane

trans-4-Methylcyclohexylisocyanate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-4-Methylcyclohexylisocyanate
IUPAC Name(1r,4r)-1-isocyanato-4-methylcyclohexane
MDL No.MFCD06411231
Molecular FormulaC8H13NO
Molecular Weight139.20
SMILESC[C@H]1CC[C@H](N=C=O)CC1
InChI KeySWSXEZOUBBVKCO-ZKCHVHJHSA-N
Synonym(1-ethoxycyclopropoxy)-trimethylsilane | SWSXEZOUBBVKCO-ZKCHVHJHSA-N | AB04647 | (1r,4r)-1-isocyanato-4-methylcyclohexane | FT-0639009 | trans-1-Isocyanato-4-methylcyclohexane | trans-4-methylcyclohexyl isocyanate | trans-4-Methyl-cyclohexyl isocyanate |
CAS No.32175-00-1
PubChem CID11423635

Safety Data

Pictogram
ToxicHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P270-P271-P280-P301+P310-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P361-P362-P363-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMWNI291 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSDHL456 route compound structure diagram
    ACSDHL45633483-65-7 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACMWNI291 route product structure diagram
    ACMWNI29132175-00-1
Inquiry

2. ACMWNI291 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSDHL456 route compound structure diagram
    ACSDHL45633483-65-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMWNI291 route product structure diagram
    ACMWNI29132175-00-1
Inquiry

Comments (0)